# FDA recall D-033-2013

> **Mylan Pharmaceuticals Inc.** · Class II · drug recall initiated 2012-08-07.

## Product

Doxazosin Tablets, USP, 2 mg, 100 count bottles, labeled in part ***Manufactured in Australia by: ALPHAPHARM PTY LTD, 15 Garnet Street***Rx Only***  Carole Park QLD 4300, Australia*** Manufactured for Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.SA ***

## Reason for recall

Cross Contamination w/Other Products: During stability testing chromatographic review revealed extraneous peaks identified as acetaminophen and codeine.

## Distribution

Nationwide.

## Key facts

- **Recall number:** D-033-2013
- **Recalling firm:** Mylan Pharmaceuticals Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2012-08-07
- **Report date:** 2012-10-31
- **Termination date:** 2013-03-27

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Morgantown, WV, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-033-2013

## Citation

> AI Analytics. FDA recall D-033-2013. Retrieved 2026-05-26 from https://api.ai-analytics.org/recall/D-033-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*